Status:
COMPLETED
Extended Spectrum Betalactamase Producing Bacteria; Epidemiology and Treatment in Non-hospitalized Patients
Lead Sponsor:
Vestre Viken Hospital Trust
Collaborating Sponsors:
Helse Sor-Ost
University Hospital of North Norway
Conditions:
Urinary Tract Infection
Infection Due to ESBL Bacteria
Eligibility:
All Genders
18+ years
Brief Summary
This project aims at investigating the duration of human fecal carriage of bacteria harboring plasmid-borne resistance genes expressing Extended Spectrum beta-lactamases (ESBL), risk factors for infec...
Eligibility Criteria
Inclusion
- Patients \>=18 of age with a urine culture yielding E. coli or K. pneumoniae \>10.000 colony forming units/mL.
Exclusion
- Patients who have lived in Norway for \<1 year
- Patients who are unable to answer a questionaire
- Patients who have been infected with an ESBL producing bacteria before
- Patients who have been admitted to a hospital or a long term care facility for \>24 hours during the past 31 days.
Key Trial Info
Start Date :
February 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
760 Patients enrolled
Trial Details
Trial ID
NCT01838213
Start Date
February 1 2009
Last Update
November 23 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.